De Euro Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.74 M
as on 14-12-2024
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.65 M
as on 14-12-2024
- Revenue -40.55%
(FY 2021)
- Profit -73.39%
(FY 2021)
- Ebitda -5.20%
(FY 2021)
- Net Worth 3.23%
(FY 2021)
- Total Assets -5.24%
(FY 2021)
About De Euro Healthcare
The Corporate was formerly known as Euro Medical Services Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.74 M.
The company currently has active open charges totaling ₹8.65 M.
Tarak Jaiswal, Bikash Jaiswal, and Ramsajiwan Shaw serve as directors at the Company.
- CIN/LLPIN
U85110WB2003PTC096403
- Company No.
096403
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at De Euro Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarak Jaiswal  | Director | 17-Jun-2003 | Current |
| Bikash Jaiswal | Director | 17-Jun-2003 | Current |
| Ramsajiwan Shaw | Director | 17-Jun-2003 | Current |
Financial Performance of De Euro Healthcare.
De Euro Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.55% decrease. The company also saw a substantial fall in profitability, with a 73.39% decrease in profit. The company's net worth moved up by a moderate rise of 3.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of De Euro Healthcare?
In 2021, De Euro Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
De Eusi Motors Private LimitedActive 6 years 11 monthsBikash Jaiswal and Ramsajiwan Shaw are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Apr 2016 | ₹2.26 M | Open |
Hdfc Bank Limited Creation Date: 15 Oct 2014 | ₹1.02 M | Open |
Hdfc Bank Limited Creation Date: 02 Mar 2012 | ₹2.40 M | Open |
How Many Employees Work at De Euro Healthcare?
Unlock and access historical data on people associated with De Euro Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of De Euro Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped De Euro Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
